BRIEF-Scibase Says EIS Technology Primary Endpoint In NIH Study

4

Oct 15 (Reuters) – SciBase Holding AB (publ): * SCIBASE'S ELECTRICAL IMPEDANCE SPECTROSCOPY (EIS) TECHNOLOGY SELECTED AS PRIMARY ENDPOINT IN NATIONAL INSTITUTE OF HEALTH (NIH) SKIN BARRIER STUDY

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)